Deltex Medical Group plc

Equities

DEMG

GB0059337583

Advanced Medical Equipment & Technology

Market Closed - London S.E. Other stock markets 09:05:05 17/07/2024 pm IST			5-day change	1st Jan Change
0.15 ^GBX	0.00%		+3.45%	+3.45%

04/07	Itim signs contract; Tekmar renews banking facilities	AN
04/07	AIM WINNERS & LOSERS: Image Scan surges on GBP3 million contract	AN

Deltex Medical Group plc Reports Group Unaudited Revenue Results for the Year Ended 31 December 2022

January 24, 2023 at 12:30 pm IST

Deltex Medical Group plc reported group unaudited revenue results for the year ended 31 December 2022. Unaudited revenues for the year ended 31 December 2022 increased by 10% to £2.5 million (2021: £2.3 million).

Latest news about Deltex Medical Group plc

Itim signs contract; Tekmar renews banking facilities	04/07	AN
AIM WINNERS & LOSERS: Image Scan surges on GBP3 million contract	04/07	AN
EARNINGS AND TRADING: Hummingbird loss narrows as revenue climbs	04/06	AN
Deltex Medical Group plc announces the successful award by NHS Supply Chain	04/06	CI
TRADING UPDATES: ECO hails vaccine results; Plant Health sales down	08/05	AN
EARNINGS: AdvancedAdvT hails "good progress" after Capita deal	02/04	AN
Earnings Flash (DEMG.L) DELTEX MEDICAL GROUP Posts FY23 Revenue GBP1.8M	28/03	MT
Earnings Flash (DEMG.L) DELTEX MEDICAL GROUP Posts FY23 Loss GBX-0.11	28/03	MT
Deltex Medical Group plc Reports Earnings Results for the Full Year Ended December 31, 2023	28/03	CI
EARNINGS AND TRADING UPDATES: GetBusy hails integration into Ultratax	18/01	AN
Deltex Medical Group plc Reports Group Unaudited Revenue Results for the Year Ended 31 December 2023	18/01	CI
Deltex Medical Logs New Orders for New TrueVue Monitor; Shares Gain	04/12	MT
Deltex Medical shares soar as TrueVue testing progresses "to plan"	04/12	AN
AIM WINNERS & LOSERS: Cornerstone FS to beat 2023 expectations	04/12	AN
Deltex Medical Group plc Announces Executive Changes	04/12	CI
Elixirr record half-year revenue; Bango profit down	18/23/18	AN
Deltex Medical Group plc Reports Earnings Results for the Half Year Ended June 30, 2023	18/23/18	CI
European stocks rattled after US debt rating cut	02/23/02	AN
Deltex Medical shares tumble following fundraising completion	02/23/02	AN
AIM WINNERS & LOSERS: Deltex plummets on return to AIM; Blancco rises	02/23/02	AN
Deltex Medical Group Tumbles 81% as Trading London Trading Resumes	02/23/02	MT
Deltex raises GBP1.9 million from fundraise; closes retail offer	24/23/24	AN
Deltex Medical Conditionally Raises GBP2 Million	24/23/24	MT
Deltex Medical extends retail offer closing date to Friday	18/23/18	AN
Deltex Medical Group Plans Capital Reorganization, GBP2 Million Equity Raise	17/23/17	MT

Chart Deltex Medical Group plc

Duration

Period

More charts

Company Profile

Deltex Medical Group Plc is a United Kingdom-based medical device company. The Company develops, manufactures and distributes a hemodynamic monitoring technology. The Company's TrueVue platform offers three monitoring technologies, such as Oesophageal Doppler Monitoring (ODM+), Pulse Pressure Waveform Analysis (PPWA) and High Definition Impedance CardioGraphy (HD-ICG). Its ODM+ is a fluid management and cardiac output monitoring technology to directly measure both flow and pressure in adults and pediatrics. HD-ICG provides continuous and sensitive measurements of cardiac output and other hemodynamic parameters. The system is stabilized using HD-Z signal filter technology. HD-ICG disposable electrodes are placed on the neck and chest. PPWA uses the researched pulse pressure wave algorithm, which is available to derive hemodynamic parameters, calibrated from the Doppler. Its applications include surgery, acute kidney injury, enhanced recovery, paediatric, and COVID-19 critical care.

Sector

Advanced Medical Equipment & Technology

Calendar

16/09/2024 - Q2 2024 Earnings Release (Projected)

More about the company